This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.
Company Profile:
Baudax Bio, Inc.
Market Cap (USD):
$1.4 M
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Vyant Bio, Inc.
Market Cap (USD):
$1.2 M
(Dec. 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Axcella Health Inc.
Market Cap (USD):
$1.2 M
(Dec. 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Evelo Biosciences, Inc.
Market Cap (USD):
$918,767
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Kaleido Biosciences, Inc.
Market Cap (USD):
$106,556
(Jan. 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Turnstone Biologics Corp.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
MultiCell Technologies, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Poniard Pharmaceuticals, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Bassline Productions, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Pathfinder Cell Therapy, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Sophiris Bio, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Lescarden, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Life Stem Genetics, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
MDECHEM, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Hemagen Diagnostics, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
IR Biosciences Holdings, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
PhaseRx, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Omnimmune Holdings, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Nanobac Pharmaceuticals, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
FluoroPharma Medical, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Health Sciences Group, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
GeneLink, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Xeno Transplants Corp
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Verde Science, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
OncoVista Innovative Therapies, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Ainos, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Quantum-Si, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Surrozen, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Statera Biopharma, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Aerovate Therapeutics, Inc.
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology